Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
775
datasets available to search
ShareScore release 0.9.0
Dataset results
775 results for “irinotecan”
Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan
ClinicalTrials.gov study NCT00183859. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Tislelizumab Combined With Cetuximab and Irinotecan in the Treatment of Recurrent, Refractory mCRC
ClinicalTrials.gov study NCT05143099. IPD Sharing: YES. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan
ClinicalTrials.gov study NCT00016978. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
ClinicalTrials.gov study NCT01847495. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC
ClinicalTrials.gov study NCT06321081. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC
ClinicalTrials.gov study NCT05229003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy
ClinicalTrials.gov study NCT00713128. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan
ClinicalTrials.gov study NCT06443307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric Cancer
ClinicalTrials.gov study NCT04934618. IPD Sharing: NO. Countries: 1. Publications: 0.
Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients
ClinicalTrials.gov study NCT06202001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
ClinicalTrials.gov study NCT00005951. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma
ClinicalTrials.gov study NCT06801730. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients
ClinicalTrials.gov study NCT04368507. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC
ClinicalTrials.gov study NCT06648525. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer
ClinicalTrials.gov study NCT00063141. IPD Sharing: Not stated. Countries: 17. Publications: 0.
Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC
ClinicalTrials.gov study NCT06739928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer
ClinicalTrials.gov study NCT00177853. IPD Sharing: Not stated. Countries: 1. Publications: 0.
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast C
ClinicalTrials.gov study NCT00031681. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer
ClinicalTrials.gov study NCT01859728. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation
ClinicalTrials.gov study NCT04627142. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.